Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2020 / Articles / Mar / Natural Evolution of NMR Methodology?
Discovery & Development Analytical Science

Natural Evolution of NMR Methodology?

How a new approach accurately determines the structure and stereochemistry of natural products that confound conventional methods

By Stephanie Vine 03/18/2020 1 min read Quick Read (pre 2022)

Share

Natural products are a common source of drugs (many antibiotics, painkillers, and even cancer drugs are derived from natural products), but before natural products can be exploited, their structures and stereochemistry must be elucidated. And that’s (unsurprisingly) easier said than done. 

“Besides the X-ray diffraction, which can only be applied to crystallizable molecules, chemists usually use nuclear magnetic resonance (NMR) spectroscopy for structure determination. Most employed NMR parameters rely on the measurement of protons. But for molecules that only contain few protons or flexible molecules that need more NMR data to define their conformational spaces, conventional proton-based NMR methods may not determine their structure and stereochemistry correctly,” says Han Sun, a researcher at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Germany.

Another NMR-based parameter – residual chemical shift anisotropy (RCSA) – can accurately determine structure and stereochemistry, but requires specialized instrumentation. But now, Sun and colleagues have developed a method that simplifies the measurement of RCSA to make it more accessible.

“Our experiment involves bringing together natural products with a commercially available peptide – with a sequence of AAKLVFF,” says Xiaolu Li, lead author of the work (1). “Dissolved in methanol, the peptides are transformed into liquid crystals, which gives the natural products a weak orientation in the magnetic field. This particular orientation enables us to measure the RCSA of the molecules as a parameter, which in turn provides accurate information about their structure and stereochemistry.”

The team tested the technique by analyzing spiroepicoccin A – which was isolated from a marine organism that lives at a depth of more than 4500 m. The substance only has a few hydrogen atoms attached to its stereocenters, making it difficult to analyze with conventional NMR, but the new technique was able to successfully elucidate the compound’s structure and stereochemistry.

According to Sun, many pharma companies use residual dipolar coupling and RCSA-based methods to characterize the structure and stereochemistry of drug-like molecules – and have expressed interest in the new technique. Meanwhile, Sun, Li and their colleagues are using the new method to elucidate the structure and stereochemistry of other new marine natural products.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Stephanie Vine

Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.

More Articles by Stephanie Vine

False

Advertisement

Recommended

False

Related Content

Electrifying R&D Acceleration
Small Molecules Analytical Science
Electrifying R&D Acceleration

December 2, 2014

0 min read

Electrochemical reaction cells are finding new applications in the pharma R&D lab that could offer big time and cost savings...

The Lab of the Future: Combining Automation with Digital Tools
Contract Development Services Analytical Science Technology and Equipment Digital Technologies
The Lab of the Future: Combining Automation with Digital Tools

February 25, 2025

6 min read

How do you scale up operations without adding headcount or significantly increasing investment in instrumentation? The answer: automation and workflow scheduling software.

SORS and the Power of Light in Pharma
Ingredients Analytical Science Technology and Equipment
SORS and the Power of Light in Pharma

January 17, 2025

7 min read

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more

Facing Up to the New Nemesis of Pharma: Nitrosamines
Quality & Compliance Small Molecules Process Control Analytical Science Ingredients
Facing Up to the New Nemesis of Pharma: Nitrosamines

September 5, 2024

8 min read

What’s going on with nitrosamines in pharmaceutical products? Naiffer Romero, Principal Scientist at the US Pharmacopeia walks us through frequently asked questions.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.